Maximal and Self-selected Walkingspeed After Knee Arthroplasty - a Prospective Cohort Study (LOVKNEE)

February 21, 2025 updated by: Lovisenberg Diakonale Hospital

MAXIMAL and SELF-SELECTED WALKING SPEED AFTER KNEE ARTHROPLASTY

The purpose of this prospective study is to explore whether maximal and self-selected walking speed in individuals with knee arthroplasty is a useful and applicable clinical measure that can provide new insights into physical function after prosthetic surgery. We will examine the progression of walking speed and other measures of physical function, and investigate if walking speed can predict postoperative function. Individuals over 55 years, scheduled for knee arthroplasty will be invited to participate. Standardized functional tests such as walking speed, sit to stand and one legged stance along with patient reported outcomes will be assessed preoperatively, three months and 12 months after surgery. The study may provide useful knowledge that can be aplied clinically in the assessment and follow-up of this patient group.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

130

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Oslo, Norway
        • Recruiting
        • Lovisenberg Diaconal Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Persons with knee osteoarthritis scheduled for knee arthroplasty at Lovisenberg Diaconal Hospital who meet the eligibility criteria

Description

Inclusion Criteria: age 55 +, living in or near the city of Oslo (up to appox 2 hours commute), sceduled for primary knee arthroplasty, able to walk independently with or without walking aids, understand and speak Norwegian sufficently to take instructions and respond to questionnaires

Exclusion Criteria:

Other reasons than osteoarthritis for knee arthroplasty, revision due to infection or failure, arthroplasty in the same or other limb during the 12 months time period, severe neurological or ohter types of disease that affects walking (e.g MS; parkinsonism, hemiplegiea)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Persons scheduled for knee arthroplasty
Age 55 or over, scheduled for primary uni or total knee arthroplasty, able to walk indepentdently with or without walkingaids, living in the eastern part of Norway within 1-2 hours commute from Oslo, able understand Norwegian for instructions and filling out forms,
Observe walking speed, both maximal and self-selected, over a 12-months period after knee arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline to 3 and 12 months in means in maximal and self-selected walking speed walikgn
Time Frame: Baseline, 3 months and 12 months after surgery
Walking speed will be measured by 10 meter self-selected and maximal walking speed, respectively. Participant will perform two repetitions of self-selected walking speed, followed by two repetitions of maximal walking speed. Mean, measured by meters per seconds, will be calculated onboth of the two different walking speeds.
Baseline, 3 months and 12 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sit-to-stand
Time Frame: Baseline, 3 months and 12 months after surgery
Lower extremity strength will be measured by 30 sec sit to stand. Number of standing up in 30 seconds will be counted and recorded
Baseline, 3 months and 12 months after surgery
One legged stance
Time Frame: Baseline, 3 months and 12 months after surgery
Balance will be measured by one legged stance. The participant will perform the test by standing on one leg and the other in 90 degrees flexion of the hip and knee, hands on hips. The test will be performed twice, with the non-affected leg to be tested first. The best of the two scores for each leg will be recorded.
Baseline, 3 months and 12 months after surgery
Knee specific function and pain
Time Frame: Baseline and 12 months
Pain and function in the knee will be measured by the patient reported form KOOS which includes 42 questions evaluating pain and function in different activities in daily life the last week.
Baseline and 12 months
EQ5D- Health-related quality of life
Time Frame: Baseline and 12 months after surgery
Measures self-reported health-related quality of life.
Baseline and 12 months after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: Baseline and 12 months after surgery
To measure physical activity UCLA activity score will be applied. UCLA is a simple scale from 1 to 10 where the participant mark the level that suits their level of activity best. 1 is the lowest, 10 the highest score.
Baseline and 12 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2024

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

February 21, 2025

First Submitted That Met QC Criteria

February 21, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 21, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 764176

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthroplasty, Total

Clinical Trials on Physical function

Subscribe